Early prognostic stratification and identification of irreversibly shocked patients despite primary percutaneous

Luca Falco1, Enrico Fabris1, Caterina Gregorio2

  • 1Cardiothoracovascular Department.

Insights

Early prognostic factors for ST-elevation myocardial infarction (STEMI) with cardiogenic shock (CS) are crucial. Advanced age and prolonged ischemia increase mortality risk, while timely percutaneous coronary intervention (PCI) improves survival in STEMI patients with CS.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Acute Coronary Syndromes

Background:

  • ST-elevation myocardial infarction (STEMI) patients with cardiogenic shock (CS) face high mortality despite advancements.
  • Early prognostic factors in this high-risk group, even after revascularization, remain poorly understood.

Purpose of the Study:

  • To identify early prognostic factors for 30-day mortality in STEMI patients presenting with CS.
  • To stratify risk using data available at first medical contact (FMC).

Main Methods:

  • Analysis of 1222 STEMI patients treated with primary percutaneous coronary intervention (PCI) from 2012-2018.
  • Development of a decision tree for 30-day mortality risk stratification based on FMC data.
  • Multivariate analysis to determine independent predictors of mortality.

Main Results:

  • Cardiogenic shock (CS) occurred in 7.5% of STEMI patients, with significantly higher 30-day mortality (33% vs 3%).
  • A high-risk subgroup (age ≥76 years, anterior STEMI, ischemia time >3h 21min) showed 85.7% 30-day mortality.
  • Independent predictors of mortality in CS patients were older age (OR 1.246), final TIMI flow 2-3 (OR 0.058), and longer ischemia time (OR 1.269).

Conclusions:

  • In STEMI with CS, advanced age is a negative prognostic factor, while early and successful PCI improves survival.
  • A subset of elderly patients experiences poor prognosis despite revascularization.
  • Identifying irreversibly critically ill patients remains challenging, and the impact of PCI in this group is uncertain.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
108
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
47
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
40
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
67
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
106
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
76